Unknown

Dataset Information

0

Electrospun Bioresorbable Membrane Eluting Chlorhexidine for Dental Implants.


ABSTRACT: To prevent the uncontrolled development of a pathogenic biofilm around a dental implant, an antimicrobial drug-release electrospun membrane, set up between the implant and the gingival tissue, was developed by taking several technical, industrial and regulatory specifications into account. The membrane formulation is made of a blend of poly(l-lactic-co-gycolic acid) (PLGA, 85:15) and poly(l-lactic acide-co-?-caprolactone) (PLC, 70:30) copolymers with chlorhexidine diacetate (CHX) complexed with ?-cyclodextrin (CD). The amount of residual solvent, the mechanical properties and the drug release kinetics were tuned by the copolymers' ratio, between 30% and 100% of PLC, and a CHX loading up to 20% w/w. The membranes were sterilized by ?-irradiation without significant property changes. The fiber's diameter was between 600 nm and 3 µm, depending on the membrane composition and the electrospinning parameters. CHX was released in vitro over 10 days and the bacterial inhibitory concentration, 80 µg·mL-1, was reached within eight days. The optimal membrane, PGLA/PLC/CHX-CD (60%/40%/4%), exhibited a breaking strain of 50%, allowing its safe handling. This membrane and a membrane without CHX-CD were implanted subcutaneous in a rat model. The cell penetration remained low. The next step will be to increase the porosity of the membrane to improve the dynamic cell penetration and tissue remodeling.

SUBMITTER: Pouponneau P 

PROVIDER: S-EPMC7023585 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Electrospun Bioresorbable Membrane Eluting Chlorhexidine for Dental Implants.

Pouponneau Pierre P   Perrey Ophélie O   Brunon Céline C   Grossiord Carol C   Courtois Nicolas N   Salles Vincent V   Alves Antoine A  

Polymers 20200102 1


To prevent the uncontrolled development of a pathogenic biofilm around a dental implant, an antimicrobial drug-release electrospun membrane, set up between the implant and the gingival tissue, was developed by taking several technical, industrial and regulatory specifications into account. The membrane formulation is made of a blend of poly(l-lactic-<i>co</i>-gycolic acid) (PLGA, 85:15) and poly(l-lactic acide-<i>co</i>-ɛ-caprolactone) (PLC, 70:30) copolymers with chlorhexidine diacetate (CHX) c  ...[more]

Similar Datasets

| S-EPMC3412890 | biostudies-literature
| 2044208 | ecrin-mdr-crc
| S-EPMC3926690 | biostudies-literature
| S-EPMC5456597 | biostudies-other
| S-EPMC5445242 | biostudies-literature
| S-EPMC8751934 | biostudies-literature
| S-EPMC6418164 | biostudies-literature
| S-EPMC7762379 | biostudies-literature
| S-EPMC5583079 | biostudies-literature